BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 38469780)

  • 61. The immunophenotypic characteristics and flow cytometric scoring system of acute myeloid leukemia with t(8;21) (q22;q22); RUNX1-RUNX1T1.
    Shang L; Chen X; Liu Y; Cai X; Shi Y; Shi L; Li Y; Song Z; Zheng B; Sun W; Ru K; Mi Y; Wang J; Wang H
    Int J Lab Hematol; 2019 Feb; 41(1):23-31. PubMed ID: 30264491
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Acute myeloid leukemia with t(14;21) involving RUNX1 and SYNE2: A novel favorable-risk translocation?
    Foley N; Van Ziffle J; Yu J; Qi Z; Grenert JP; Yeh I; Bastian B; Kogan S; Mannis GN
    Cancer Genet; 2017 Oct; 216-217():74-78. PubMed ID: 29025598
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Myeloid translocation gene CBFA2T3 directs a relapse gene program and determines patient-specific outcomes in AML.
    Steinauer N; Guo C; Huang C; Wong M; Tu Y; Freter CE; Zhang J
    Blood Adv; 2019 May; 3(9):1379-1393. PubMed ID: 31040112
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Comprehensive mutational profiling of core binding factor acute myeloid leukemia.
    Duployez N; Marceau-Renaut A; Boissel N; Petit A; Bucci M; Geffroy S; Lapillonne H; Renneville A; Ragu C; Figeac M; Celli-Lebras K; Lacombe C; Micol JB; Abdel-Wahab O; Cornillet P; Ifrah N; Dombret H; Leverger G; Jourdan E; Preudhomme C
    Blood; 2016 May; 127(20):2451-9. PubMed ID: 26980726
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Characterization of bone marrow mast cells in acute myeloid leukemia with t(8;21) (q22;q22); RUNX1-RUNX1T1.
    Pullarkat ST; Pullarkat V; Lagoo A; Brynes R; Weiss LM; Bedell V; Chen W; Huang Q; Gaal K; Weisenburger DD; Kim YS
    Leuk Res; 2013 Nov; 37(11):1572-5. PubMed ID: 24035334
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Acute myeloid leukemia (M2) with a cryptic RUNX1/RUNX1T1 t(1;21;8)(p36;q22;q22) variant.
    Tirado CA; Chen W; Valdez FJ; Henderson S; Doolittle J; Garcia R; Patel S; Holdridge S; Chastain C; Collins RH
    Cancer Genet Cytogenet; 2009 Aug; 193(1):67-9. PubMed ID: 19602466
    [No Abstract]   [Full Text] [Related]  

  • 67. Acute myeloid leukemia with new complex t(8;21;22) induced hemophagocytic lymphohistiocytosis: A case report.
    Wu Y; Xu J; Shen K; Ji J; Yang C; Liu T; Xiang B
    Medicine (Baltimore); 2018 Nov; 97(44):e12762. PubMed ID: 30383631
    [TBL] [Abstract][Full Text] [Related]  

  • 68. UBC9 inhibits myeloid differentiation in collaboration with AML1-MTG8.
    Fukuyama T; Kitamura T; Kozu T
    Int J Hematol; 2022 May; 115(5):686-693. PubMed ID: 35152350
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Dual intron-targeted CRISPR-Cas9-mediated disruption of the AML RUNX1-RUNX1T1 fusion gene effectively inhibits proliferation and decreases tumor volume in vitro and in vivo.
    Neldeborg S; Soerensen JF; Møller CT; Bill M; Gao Z; Bak RO; Holm K; Sorensen B; Nyegaard M; Luo Y; Hokland P; Stougaard M; Ludvigsen M; Holm CK
    Leukemia; 2023 Sep; 37(9):1792-1801. PubMed ID: 37464068
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Core binding factor acute myeloid leukemia: the impact of age, leukocyte count, molecular findings, and minimal residual disease.
    Hoyos M; Nomdedeu JF; Esteve J; Duarte R; Ribera JM; Llorente A; Escoda L; Bueno J; Tormo M; Gallardo D; de Llano MPQ; Martí JM; Aventín A; Mangues R; Brunet S; Sierra J
    Eur J Haematol; 2013 Sep; 91(3):209-218. PubMed ID: 23646898
    [TBL] [Abstract][Full Text] [Related]  

  • 71. A Novel Three-Way Variant t(8;13;21)(q22;q33;q22) in a Child with Acute Myeloid Leukemia with RUNX1/RUNX1T1 : The Contribution of Molecular Approaches for Revealing t(8;21) Variants.
    de Matos RR; De Figueiredo AF; Liehr T; Alhourani E; De Souza MT; Binato R; Ribeiro RC; Silva ML
    Acta Haematol; 2015; 134(4):243-5. PubMed ID: 26138995
    [No Abstract]   [Full Text] [Related]  

  • 72. AML1-ETO inhibits acute myeloid leukemia immune escape by CD48.
    Wang Z; Guan W; Wang M; Chen J; Zhang L; Xiao Y; Wang L; Li Y; Yu L
    Leuk Lymphoma; 2021 Apr; 62(4):937-943. PubMed ID: 33225787
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Simultaneous occurrence of two distinct leukemic clones with PML-RARα and RUNX1-RUNX1T1 in a case of acute myeloid leukemia.
    Shao H; Yang Q; Zhang P; Liu H; Wu C; Cen J; Qiu H; Chen S; Pan J
    Ann Hematol; 2018 Mar; 97(3):529-531. PubMed ID: 29124313
    [No Abstract]   [Full Text] [Related]  

  • 74. The RUNX1/RUNX1T1 network: translating insights into therapeutic options.
    Swart LE; Heidenreich O
    Exp Hematol; 2021 Feb; 94():1-10. PubMed ID: 33217477
    [TBL] [Abstract][Full Text] [Related]  

  • 75. High aldehyde dehydrogenase activity at diagnosis predicts relapse in patients with t(8;21) acute myeloid leukemia.
    Yang L; Chen WM; Dao FT; Zhang YH; Wang YZ; Chang Y; Liu YR; Jiang Q; Zhang XH; Liu KY; Huang XJ; Qin YZ
    Cancer Med; 2019 Sep; 8(12):5459-5467. PubMed ID: 31364309
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Subgroup Analysis Can Optimize the Relapse-Prediction Cutoff Value for WT1 Expression After Allogeneic Hematologic Stem Cell Transplantation in Acute Myeloid Leukemia.
    Qin YZ; Wang Y; Xu LP; Zhang XH; Zhao XS; Liu KY; Huang XJ
    J Mol Diagn; 2020 Feb; 22(2):188-195. PubMed ID: 31751675
    [TBL] [Abstract][Full Text] [Related]  

  • 77. KIT D816 mutation associates with adverse outcomes in core binding factor acute myeloid leukemia, especially in the subgroup with RUNX1/RUNX1T1 rearrangement.
    Kim HJ; Ahn HK; Jung CW; Moon JH; Park CH; Lee KO; Kim SH; Kim YK; Kim HJ; Sohn SK; Kim SH; Lee WS; Kim KH; Mun YC; Kim H; Park J; Min WS; Kim HJ; Kim DH;
    Ann Hematol; 2013 Jan; 92(2):163-71. PubMed ID: 23053179
    [TBL] [Abstract][Full Text] [Related]  

  • 78. A Novel KIT INDEL Mutation in Acute Myeloid Leukemia With t(8;21)(q22;q22); RUNX1-RUNX1T1.
    Lee JH; Park C; Kim SH; Shin MG
    Ann Lab Med; 2016 Jul; 36(4):371-4. PubMed ID: 27139612
    [No Abstract]   [Full Text] [Related]  

  • 79. Coexistent t(8;21)(q22;q22) Translocation and 5q Deletion in Acute Myeloid Leukemia.
    Yamamoto K; Yakushijin K; Sanada Y; Kawamoto S; Matsuoka H; Minami H
    J Clin Exp Hematop; 2015; 55(3):181-5. PubMed ID: 26763368
    [TBL] [Abstract][Full Text] [Related]  

  • 80. A novel four-way t(6;16;21;8)(p21.3;p11.2;q22;q22) in acute myeloid leukemia with RUNX1/RUNX1T1 rearrangement.
    Park KJ; Park HD; Kim HJ; Yoo KH; Koo HH; Kim SH
    Cancer Genet Cytogenet; 2009 Jul; 192(2):90-2. PubMed ID: 19596262
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.